Article Information
- Received April 11, 2001
- Revision received July 9, 2001
- Accepted July 27, 2001
- First published October 15, 2001.
- Version of record published October 15, 2001.
Author Information
- 1Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, S-17177 Stockholm, Sweden, and
- 2Departments of Neurology, Pediatrics and Neurosurgery, Harvard Medical School and Division of Neuroscience, Children's Hospital, Boston, Massachusetts 02115
Author contributions
Disclosures
- Received April 11, 2001.
- Revision received July 9, 2001.
- Accepted July 27, 2001.
This work was supported by the European Commission, the Swedish Medical Research Council, the Swedish Foundation for Strategic Research, the Karolinska Institute, and the Petrus och Augusta Hedlunds, Jeanssonska, Kapten Arthur Eriksson, and Axel och Signe Lagermans Foundations. E.Y.S was supported by grants from the National Institute of Neurological Diseases and Stroke and The Parkinson's Action Network. J.M.C. was supported by a short-term European Molecular Biology Organization and a Human Frontier Science Program fellowships. We thank Dr. Joseph Wagner for critical reading of this manuscript, Lotta Johansson for secretarial help, and Annika Ahlsen for additional assistance.
Requests for parental c17.2 cells should be addressed to Evan Y. Snyder. E-mail: snyder{at}a1.tch.harvard.edu.
Correspondence and requests for materials and GDNF-c17.2 cells should be addressed to Ernest Arenas, Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Berzeliusväg 3, Karolinska Institute, S-17177 Stockholm, Sweden. E-mail:ernest{at}cajal.mbb.ki.se.
J. M. Canals's present address: Department of Cell Biology and Pathology, Facultat de Medicina, Universitat de Barcelona, Institut de Investigacions Biomèdiques August Pi i Sunyer, Casanova 143, 08036 Barcelona, Spain.
Online Impact